The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
The company will address the observations within a stipulated timeline working with the regulators
There is also a growing interest in whole generation sequencing (WGS)
Transformation to pure-play Innovative Medicines company nears completion
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
_256_384.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
Subscribe To Our Newsletter & Stay Updated
